The Trump admin has another pretty good, pretty modest plan to lower drug costs image

Vox, August 13, 2018
Dylan Scott, quoting Rachel E. Sachs (Academic Fellow Alumna)


Read the Full Article

From the article:

“My concern is that once again, the administration’s rhetoric is out of step with its actual policy moves,” Sachs said. “The administration is promoting this move as a fundamental transformation, as delivering on the president’s statements about drug price negotiation – and it’s much less than that.”

“The mismatch between the rhetoric and the action makes it hard to figure out what the administration is actually attempting to do here,” she continued. “Will this be their only action, and they’re aiming to frame it as far more consequential than it is? I’m not sure.”

Read the full article!

health care costs health law policy insurance medicaremedicaid pharmaceuticals regulation